How to buy Mayne Pharma Group (MYX) shares
Learn how to easily invest in Mayne Pharma Group shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Mayne Pharma Group Limited is a drug manufacturers-general business based in Australia. Mayne Pharma Group shares (MYX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Mayne Pharma Group has a trailing 12-month revenue of around $400.8 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Mayne Pharma Group
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Mayne Pharma Group. Find the share by name or ticker symbol: MYX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mayne Pharma Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Mayne Pharma Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Mayne Pharma Group stock price (ASX:MYX)Use our graph to track the performance of MYX stocks over time.
Mayne Pharma Group shares at a glance
|52-week range||$0.26 - $0.515|
|50-day moving average||$0.2977|
|200-day moving average||$0.3492|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.133|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Mayne Pharma Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mayne Pharma Group price performance over time
|1 week (2021-09-17)||0.295|
|1 month (2021-08-25)||-1.67%|
|3 months (2021-06-25)||-11.94%|
|6 months (2021-03-25)||-13.24%|
|1 year (2020-09-25)||-18.06%|
|2 years (2019-09-25)||-41.00%|
|3 years (2018-09-25)||-76.49%|
|5 years (2016-09-23)||-85.54%|
Is Mayne Pharma Group under- or over-valued?
Valuing Mayne Pharma Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mayne Pharma Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mayne Pharma Group's EBITDA
Mayne Pharma Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $50 million (£0.0 million).
The EBITDA is a measure of a Mayne Pharma Group's overall financial performance and is widely used to measure a its profitability.
Mayne Pharma Group financials
|Revenue TTM||$400.8 million|
|Gross profit TTM||$182 million|
|Return on assets TTM||-0.47%|
|Return on equity TTM||-23.05%|
|Market capitalisation||$520.6 million|
TTM: trailing 12 months
Mayne Pharma Group share dividends
We're not expecting Mayne Pharma Group to pay a dividend over the next 12 months.
Mayne Pharma Group share price volatility
Over the last 12 months, Mayne Pharma Group's shares have ranged in value from as little as $0.26 up to $0.515. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Mayne Pharma Group's is 0.9316. This would suggest that Mayne Pharma Group's shares are less volatile than average (for this exchange).
Mayne Pharma Group overview
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Asia, and internationally. The company operates through four segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Stocks similar to Mayne Pharma Group
Mayne Pharma Group in the news
Mayne Pharma : FDA APPROVES LEXETTEO FOR ADOLESCENT PLAQUE PSORIASIS
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
Trade Alert: The Independent Non-Executive Director Of Mayne Pharma Group Limited (ASX:MYX), Frank Condella, Has Just Spent AU$137k Buying 120% More Shares
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert